Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Alliance Grants

University of Calgary

$59,415.00

Optimization of vaccination strategies for table egg layers controlling egg production problems induced by currently circulating infectious bronchitis virus (IBV) variants

FY 2023-24

Summary
In 2019, Canada's poultry industry has an annual turnover of 176 million birds and >9.6 billion eggs and contributed $4.9 billions to the national economy. A respiratory viral infection caused by infectious bronchitis virus (IBV) is economically important for poultry industry in general and table egg layer industry in particular. The IBV replicates in young and adult chickens and the primary lesions are observed in the respiratory, reproductive and urinary systems depending on the infecting IBV strain. Consequently, IBV infections may lead to mortality in young chickens and reduced egg production and quality in layers, limiting the profitability of poultry production. For the control of clinical disease caused by IBV, live attenuated viral vaccines are available. The emergence of new "variant" and more heterogeneous IBV strains, has led to infectious bronchitis (IB) outbreaks in vaccinated flocks resulting in significant production losses. This is due to the lack of development of cross protective immunity. Similar outbreaks of IB in layers affecting egg production have been observed in Eastern and Western Canada. The predominant IBV variants causing egg production abnormalities are different in Western and Eastern Canada. In Eastern Canada, false layer syndrome (FLS) caused by the Delmarva (DMV) variant IBV has been an issue since 2017. The causative IBV strains of FLS are isolated, molecularly characterized and experimental models are established already.In the proposed project, we will optimize vaccination strategies against FLS and other egg production abnormalities induced by DMV IBV variant isolated from chickens raised in Eastern Canada using currently available IBV vaccines in Canada. Then, we will propose vaccine based control strategies for the benefit of the poultry industry in Canada.
Program
Alliance Grants
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
561405-2020
Name nom
Abdul Careem, Mohamed Faizal MF
Department département
Veterinary Medicine, Faculty of
Organization id
11
Institution établissement
University of Calgary
Province en
Alberta
Province fr
Alberta
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2023
Competition year année de concours
2020
Award amount
59415
Program id
ALLRP
Program name en
Alliance Grants
Program name fr
Subventions Alliance
Group en
RESEARCH PARTNERSHIPS
Group fr
PARTENARIATS DE RECHERCHE
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
102
Area of application group en
Agriculture and primary food production
Area of application group fr
Agriculture et produits alimentaires primaires
Area of application en
Animal management (animal diseases, breeding)
Area of application fr
Gestion des animaux (maladies animales, reproduction)
Research subject code
5202
Research subject group en
Microbiology
Research subject group fr
Virology
Research subject en
Microbiologie
Research subject fr
Virologie
Application title
Optimization of vaccination strategies for table egg layers controlling egg production problems induced by currently circulating infectious bronchitis virus (IBV) variants
Keyword
Antibody-mediated immune response; Cell-mediated immune response; Chicken; Egg production; False layer syndrome; Immune response; Infectious bronchitis virus; reproductive tract; Shell-less egg syndrome; Vaccine efficacy
Application summary
In 2019, Canada's poultry industry has an annual turnover of 176 million birds and >9.6 billion eggs and contributed $4.9 billions to the national economy. A respiratory viral infection caused by infectious bronchitis virus (IBV) is economically important for poultry industry in general and table egg layer industry in particular. The IBV replicates in young and adult chickens and the primary lesions are observed in the respiratory, reproductive and urinary systems depending on the infecting IBV strain. Consequently, IBV infections may lead to mortality in young chickens and reduced egg production and quality in layers, limiting the profitability of poultry production. For the control of clinical disease caused by IBV, live attenuated viral vaccines are available. The emergence of new "variant" and more heterogeneous IBV strains, has led to infectious bronchitis (IB) outbreaks in vaccinated flocks resulting in significant production losses. This is due to the lack of development of cross protective immunity. Similar outbreaks of IB in layers affecting egg production have been observed in Eastern and Western Canada. The predominant IBV variants causing egg production abnormalities are different in Western and Eastern Canada. In Eastern Canada, false layer syndrome (FLS) caused by the Delmarva (DMV) variant IBV has been an issue since 2017. The causative IBV strains of FLS are isolated, molecularly characterized and experimental models are established already.In the proposed project, we will optimize vaccination strategies against FLS and other egg production abnormalities induced by DMV IBV variant isolated from chickens raised in Eastern Canada using currently available IBV vaccines in Canada. Then, we will propose vaccine based control strategies for the benefit of the poultry industry in Canada.